Commerce Regulations 1913 (Amendment)

Overview

The Statutory Rules of 1917, No. 286, introduced under the Commerce (Trade Descriptions) Act 1905, were enacted to amend the Commerce Regulations 1913, specifically addressing the need for clearer and more detailed trade descriptions for antitoxin, serum, and other biological preparations. The problem this legislation aimed to resolve was the lack of explicit labelling requirements for these medicinal products, which could potentially mislead consumers and pose health risks. The regulation was enacted by the Governor-General in and over the Commonwealth of Australia, acting with the advice of the Federal Executive Council, with the intent to ensure that consumers have access to accurate and comprehensive information regarding the contents and quality of these preparations. The overarching policy objective was to safeguard public health by mandating the provision of detailed and transparent labelling on biological preparations intended for medicinal, prophylactic, or therapeutic purposes.

Scope and Application

The statutory rule, made under the Commerce (Trade Descriptions) Act 1905, governs the labelling requirements for antitoxin, serum, and other biological preparations used for medicinal, prophylactic, or therapeutic purposes, or for use as, or in the preparation of, articles of food or drink for humans. The regulation mandates that these products must have a trade description directly attached to the container, detailing specific information such as the name of the manufacturer, the exact name of the preparation, the volume or weight of the content, the manufacture date, and the expiration date. Additionally, it requires the disclosure of any antiseptic additives, the number of immunising units for diphtheria and tetanus antitoxic sera, and the identity and number of organisms per cubic centimetre for bacterial vaccines. The rule also applies to the sterility and presence of free toxin in antitoxins and the absence of organisms other than those specific to the preparation. The regulation applies to all such biological preparations within the Commonwealth of Australia, and its application extends to institutions, corporations, firms, and individuals involved in the manufacture and distribution of these products. The stated exclusions and exemptions are not specified in this particular statutory rule, although it is implied that the regulation applies broadly to all relevant biological preparations within the Commonwealth.

Key Provisions

The primary focus of the statutory rules under the Commerce (Trade Descriptions) Act 1905 is the regulation of trade descriptions for biological preparations such as antitoxins, serums, and other substances intended for medicinal, prophylactic, or therapeutic purposes, or for use as, or in the preparation of, food or drink (Regulation 8(fb)). This amendment, repealing Regulation 8(fb) of the Commerce Regulations 1913, mandates that the trade description of these biological preparations must be directly attached to the container. The description must include several specific details to ensure transparency and safety. These details include the name of the manufacturer, the exact name of the preparation, the exact volume or weight of the content, the date of manufacture, the expiry date, and the nature and percentage of any antiseptics added (if applicable). Additionally, for diphtheria and tetanus antitoxic sera, the number of immunising units and whether the serum has been concentrated must be specified. For bacterial vaccines, the identity and number of organisms per cubic centimetre and the maximal doses for administration must be listed. Finally, the description must indicate whether the content is free from organisms other than those peculiar to the preparation and, in the case of antitoxins, whether the content is sterile or contains any free toxin. The obligations imposed by these regulations are clear and specific, aimed at ensuring that consumers and healthcare providers have all necessary information to safely and effectively use these preparations. Manufacturers, institutions, corporations, firms, and individuals involved in the production and distribution of these biological preparations must adhere to the prescribed format and content for the trade descriptions. Failure to include all required information or inaccuracies in the description could lead to significant health risks and legal repercussions. Breaches of these regulations may lead to serious consequences. While the statutory rules do not explicitly detail the penalties for non-compliance, the Commerce (Trade Descriptions) Act 1905, under which these regulations are made, provides a framework for enforcement. Typically, penalties for breaches of such regulations can include fines and, in severe cases, criminal charges. The exact penalties would be determined by the courts, but they could potentially involve substantial financial penalties and, in cases of gross negligence, imprisonment. It is essential for manufacturers and distributors to comply fully with these regulations to avoid any legal ramifications.